AACR 2026 现场信号· @ · X·· 2026-04-22评分60
正文 · 原文
Read "Advanced CD276-targeting dual payload antibody-drug conjugates for cancer therapy" from Xiaoguang Liu's group, published simultaneously with an #AACR26 poster presentation today. https://t.co/vgn79g5rmD
#OpenAccess https://t.co/y1EzOzz73O
热度 0 · 0 赞 · 0 回复 · 0 转发
会议摘要
5237按 代号 CD276 对上
The significant co-expression of claudin-3(CLDN3) and B7-H3(CD276) as a potential biomarker for targeted therapy in neuroendocrine carcinomasJi-Hye Nam, Ju-Yeon Kim, Jae Choi, Minjung Sung, Jae Hwan Kang, Hobin Yang, Yoon-la Choi, Young Kee Shin
读摘要原文 →5367按 代号 CD276 对上
Clinical and molecular features of CD276 (B7H3) in liver metastases of pancreatic cancer.Go Igarashi, Shuichi Mitsunaga, Nobuaki Okumura, Kanae Inoue, Tomonao Taira, Taro Shibuki, Tomoyuki Satake, Masataka Amisaki, Mitsuhito Sasaki, Hideaki Takahashi, Hiroshi Imaoka, Masafumi Ikeda
读摘要原文 →来源：AACR 2026 现场信号 · x.com